Monday, September 11, 2017

Hemas Pharmaceuticals opens in Myanmar

Senior management members from Hemas Holdings PLC, Hemas Pharmaceuticals and Hemas Mandalar Pharmaceuticals Ltd together with K.W.N.D. Karunaratne, Ambassador of Sri Lanka for Myanmar at the launch celebrations

Hemas Pharmaceuticals, the leading pharmaceutical importer and distributor in Sri Lanka, ventured into regional shores for the first time with its entry into Myanmar to commence distribution operations as Hemas Mandalar Pharmaceuticals Ltd.

Hemas Mandalar Pharmaceuticals Ltd, in partnership with Family Mandalar Company, would serve as the main distribution point for multinational and other pharmaceutical manufacturers that would enable the supply of quality pharmaceutical products across Myanmar. Ashwani Bagga, a veteran in the pharmaceutical industry with over 25 years of cross cultural exposure, will be leading operations in the capacity of Chief Executive Officer for the organisation.

Commenting on the strategic move, Group Chief Executive Officer of Hemas Holdings PLC, Steven Enderby said, “Myanmar has been a core part of Hemas Pharmaceutical’s vision to expand regionally, a venture that we have been actively and energetically pursuing over the last three years.”

“It was therefore important to us to partner with a well-established and reputed organisation such as the Family Mandalar Company with values that are aligned with ours to take on the challenging task of expanding our distribution operations beyond our own borders.”

Managing Director of Hemas Pharmaceuticals Kasturi Wilson said, “as a result of this endeavour, we are able to take our expertise, our best-in-class processes, and infrastructure outside of Sri Lanka to add value to other markets.”

Hemas Mandalar Pharmaceuticals Ltd will engage its core strengths of an extensive distribution network, well trained and highly experienced sales team, and the usage of real time sales data to ensure a smooth and efficient flow of operations in Myanmar.

Ashwani Bagga, Chief Executive Officer of Hemas Mandalar Pharmaceuticals Ltd said, “Through Hemas Mandalar Pharmaceuticals, we will focus on adding value to the nation’s healthcare industry by exploring means of introducing new healthcare solutions to the people of Myanmar. In the process, it will create over 100 new job opportunities thus far in Myanmar and we intend to create many more job opportunities in the future as well.” 

 

Author:

Related Posts:

0 comments: